Brello Health Review 2026

Brello charges $399 for a three-month compounded semaglutide plan and $499 for a three-month compounded tirzepatide plan. That works out to about $133 and $166 per month, but the total is billed as a plan rather than monthly. The checkout terms say each plan renews at the same total every 11 weeks until canceled. Provider review, prescribed medication, supplies, shipping, app features, fitness and nutrition classes, and community access are included. There is no separate membership fee, but the three-month commitment functions like one.

Brello is a coordination platform and not the clinician or pharmacy. Independent healthcare providers review patient information and decide whether to prescribe, while Brello's terms identify AP Max, Inc., doing business as Southend Pharmacy, as the current fulfillment partner. This disclosure makes the care chain easier to follow. The medications are compounded and are not FDA approved as finished products, so patients should check the pharmacy label, concentration, dosing directions, and storage instructions for each shipment.

Brello asks patients to select and pay for a plan before completing the online medical intake. A healthcare provider then reviews the information and chooses the appropriate consultation type. Approval is not guaranteed, and Brello says a declined patient receives a full refund. The order sequence is simple, but paying before medical review makes the refund rules especially important. Patients should enter current medication use and the shipping address carefully because post-prescription changes and refunds are limited.

Brello offers compounded semaglutide and tirzepatide as standalone three-month plans. It also lists NAD+, sermorelin, MICC, and multi-medication longevity plans. A provider decides which products are appropriate, and some listed combinations may not be approved for every patient. The company does not publish a universal dose ladder or lab protocol for its GLP-1 plans, so those details should be confirmed with the assigned provider rather than inferred from the price page.

Brello says approved orders ship in two to three business days for most states, but its refund and FAQ pages also warn that a pharmacy facility transition can create state-specific delays. The live status map is therefore more useful than one general estimate. Tracking arrives by email. Dispensed medications are nonrefundable, concerns about a dispensing error should be reported to the pharmacy within 48 hours, and Brello does not promise a free replacement when the carrier marks a package delivered.

The plan includes access to provider support and customer service, plus messaging through the Brello app. Brello also publishes an email address and phone number for refund and cancellation questions. The platform does not state one guaranteed response time. Because refund eligibility can depend on emailing within 24 hours of the completed provider review, patients should use the written support channel and keep the confirmation.

Brello's site explains the four-step flow and lists the total charge, included services, and renewal cycle. The app adds progress tracking and care-team contact after enrollment. The main usability risk is the use of monthly equivalents for plans billed three months at a time, especially because the renewal interval is 11 weeks rather than three calendar months. Reading the checkout total and next charge date prevents that detail from being missed.